Joon Lee
Stock Analyst at Truist Securities
(4.80)
# 75
Out of 5,174 analysts
116
Total ratings
61.74%
Success rate
48.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $490 → $525 | $448.62 | +17.03% | 5 | Mar 11, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $500 → $700 | $294.65 | +137.57% | 8 | Feb 20, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $185.01 | +24.32% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $677.50 | +52.03% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $54.09 | +84.88% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $11.63 | +329.92% | 4 | Dec 15, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $28.40 | +93.66% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $12.81 | +9.29% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $18.50 | +386.49% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $28.22 | +55.92% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $64.54 | +33.25% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $32.17 | +133.14% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $10.29 | +104.08% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $33.82 | +343.52% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $158.75 | +25.98% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $46.43 | +158.45% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.57 | +293.87% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.68 | +139.52% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $23.07 | +56.05% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.25 | +255.56% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $6.46 | +163.16% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.13 | +21.07% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.92 | +359.18% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.64 | +16,973.17% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $63.02 | -46.05% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Mar 11, 2026
Maintains: Buy
Price Target: $490 → $525
Current: $448.62
Upside: +17.03%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Buy
Price Target: $500 → $700
Current: $294.65
Upside: +137.57%
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $185.01
Upside: +24.32%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $677.50
Upside: +52.03%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $54.09
Upside: +84.88%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $11.63
Upside: +329.92%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $28.40
Upside: +93.66%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $12.81
Upside: +9.29%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $18.50
Upside: +386.49%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $28.22
Upside: +55.92%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $64.54
Upside: +33.25%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $32.17
Upside: +133.14%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $10.29
Upside: +104.08%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $33.82
Upside: +343.52%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $158.75
Upside: +25.98%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $46.43
Upside: +158.45%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $4.57
Upside: +293.87%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.68
Upside: +139.52%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $23.07
Upside: +56.05%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.25
Upside: +255.56%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.46
Upside: +163.16%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.13
Upside: +21.07%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.92
Upside: +359.18%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.64
Upside: +16,973.17%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $63.02
Upside: -46.05%